NSABP B - 24研究中他莫昔芬所致中风的发生情况。 - Suppr

Suppr

超能文献

Occurrence of stroke with tamoxifen in NSABP B-24.

作者信息

Dignam J J, Fisher B

出版信息

Lancet. 2000 Mar 4;355(9206):848-9. doi: 10.1016/S0140-6736(05)72466-1.

DOI:10.1016/S0140-6736(05)72466-1

PMID:10711957

Abstract

摘要

相似文献

Occurrence of stroke with tamoxifen in NSABP B-24.

Lancet. 2000 Mar 4;355(9206):848-9. doi: 10.1016/S0140-6736(05)72466-1.

Leiomyoma of the breast in a 50-year-old woman receiving tamoxifen.

AJR Am J Roentgenol. 1998 Dec;171(6):1684-6. doi: 10.2214/ajr.171.6.9843313.

Two case reports of ovarian cancer after long-term tamoxifen treatment for breast cancer.

J Obstet Gynaecol. 2002 Sep;22(5):572-3. doi: 10.1080/014436102760299015.

High-grade endometrial stromal sarcoma following tamoxifen treatment.

Gynecol Oncol. 2008 Jan;108(1):253-4. doi: 10.1016/j.ygyno.2007.09.002. Epub 2007 Oct 24.

Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.

Am J Obstet Gynecol. 2000 Aug;183(2):507-8. doi: 10.1067/mob.2000.105966.

The nature of tamoxifen action in the control of female breast cancer.

In Vivo. 2001 Jul-Aug;15(4):319-25.

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

Lancet. 2003 Oct 4;362(9390):1154; author reply 1155-6. doi: 10.1016/S0140-6736(03)14474-1.

Uterine sarcoma associated with tamoxifen use: case report.

Eur J Gynaecol Oncol. 2003;24(2):202-3.

Tamoxifen in ductal carcinoma in situ.

Semin Oncol. 2006 Dec;33(6):647-9. doi: 10.1053/j.seminoncol.2006.08.019.

The cerebrovascular risks associated with tamoxifen use.

Expert Opin Drug Saf. 2005 May;4(3):501-7. doi: 10.1517/14740338.4.3.501.

引用本文的文献

The Incident Ocular Diseases Related to Chemotherapy in Cancer Patients are Associated with Increasing Risk of Incident Stroke.

Acta Cardiol Sin. 2023 May;39(3):435-448. doi: 10.6515/ACS.202305_39(3).20221005A.

Cardiovascular events and mortality in a population-based cohort initially diagnosed with ductal carcinoma in situ.

BMC Cancer. 2021 Jun 26;21(1):735. doi: 10.1186/s12885-021-08494-0.

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study.

BMC Cancer. 2012 May 1;12:161. doi: 10.1186/1471-2407-12-161.

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.

Arq Bras Endocrinol Metabol. 2010 Mar;54(2):200-5. doi: 10.1590/s0004-27302010000200016.

SERMs and SERMs with estrogen for postmenopausal osteoporosis.

Rev Endocr Metab Disord. 2010 Dec;11(4):253-9. doi: 10.1007/s11154-010-9137-1.

Designing the ideal selective estrogen receptor modulator--an achievable goal?

Menopause. 2009 May-Jun;16(3):609-15. doi: 10.1097/gme.0b013e3181906fa3.

Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease.

Stroke. 2009 Jan;40(1):147-55. doi: 10.1161/STROKEAHA.108.518621. Epub 2008 Oct 23.

Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase model.

J Steroid Biochem Mol Biol. 2008 Jan;108(1-2):1-7. doi: 10.1016/j.jsbmb.2007.04.005. Epub 2007 Sep 7.

Tamoxifen-associated vasculitis in a breast cancer patient.

World J Surg Oncol. 2007 Jan 23;5:9. doi: 10.1186/1477-7819-5-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验